UK projects growth in drug spending through 2014

04/15/2013 | PharmaTimes (U.K.)

Annual spending in the U.K. will increase by 0.5% to 1.8% on branded drugs and 10% to 11% on generics through 2015, according to the Office of Health Economics. Analysts used a new "bottom-up" method to base the forecast on input from industry executives regarding new branded products as well as generic and biosimilar drugs.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID